Cargando…

Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination

BACKGROUND AND AIMS: The newly developed direct‐acting antivirals have revolutionized the treatment of chronic hepatitis C virus (HCV), with cure rates as high as 98% in some cohorts. Although genome sequencing has demonstrated that some subtypes of HCV naturally harbor drug resistance associated su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adeboyejo, Kazeem, King, Barnabas J., Tsoleridis, Theocharis, Tarr, Alexander W., McLauchlan, John, Irving, William L., Ball, Jonathan K., McClure, C. Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092547/ https://www.ncbi.nlm.nih.gov/pubmed/36168235 http://dx.doi.org/10.1002/jmv.28178

Ejemplares similares

Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom–Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa( )
por: Aranday-Cortes, Elihu, et al.
Publicado: (2021)

Enterovirus D68 epidemic, UK, 2018, was caused by subclades B3 and D1, predominantly in children and adults, respectively, with both subclades exhibiting extensive genetic diversity
por: Howson-Wells, Hannah C., et al.
Publicado: (2022)

Identification of Infectious Agents in High-Throughput Sequencing Data Sets Is Easily Achievable Using Free, Cloud-Based Bioinformatics Platforms
por: Chappell, Joseph G., et al.
Publicado: (2019)

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
por: Urbanowicz, Richard A., et al.
Publicado: (2016)

Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil
por: Adeboyejo, Kazeem, et al.
Publicado: (2022)

Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes
por: Chellapuri, Akhil, et al.
Publicado: (2022)

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment
por: McLauchlan, D., et al.
Publicado: (2017)

Retrieval of the Complete Coding Sequence of the UK-Endemic Tatenale Orthohantavirus Reveals Extensive Strain Variation and Supports Its Classification as a Novel Species
por: Chappell, Joseph G., et al.
Publicado: (2020)

Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus
por: Simmonds, Peter, et al.
Publicado: (2020)

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank
por: McLauchlan, J, et al.
Publicado: (2017)

The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks
por: Francis, Rodric V, et al.
Publicado: (2021)

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay
por: Urbanowicz, Richard A., et al.
Publicado: (2016)

Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort
por: Bagasi, Arwa A., et al.
Publicado: (2020)

Flexible and rapid construction of viral chimeras applied to hepatitis C virus
por: McClure, C. Patrick, et al.
Publicado: (2016)

Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits
por: Tsoleridis, Theocharis, et al.
Publicado: (2019)

Magnetic resonance /
por: McLauchlan, K. A.
Publicado: (1972)

Fees for Medical Reports for Life Assurance
por: Slater, D. McLauchlan
Publicado: (1888)

Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020
por: Michael, Edwin, et al.
Publicado: (2017)

Babies born under 1000 g--perinatal outcome.
por: Wilson, D. C., et al.
Publicado: (1996)

A novel way to secure a chest drain
por: Maritz, D, et al.
Publicado: (2014)

Eliminating malaria in a sub-Saharan Africa: debate it or just do it?
por: Steketee, Richard W
Publicado: (2012)

Are we ready for Taenia solium cysticercosis elimination in sub-Saharan Africa?
por: JOHANSEN, MARIA VANG, et al.
Publicado: (2017)

Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination
por: Tumba, Nuhu, et al.
Publicado: (2022)

Plasmodium vivax in Sub-Saharan Africa: An Advancing Threat to Malaria Elimination?
por: Oboh-Imafidon, Mary Aigbiremo, et al.
Publicado: (2023)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Reversing the trend: interventions to treat intracranial haemorrhage associated with anticoagulation
por: McLauchlan, D., et al.
Publicado: (2016)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis
por: McLauchlan, D., et al.
Publicado: (2020)

Evaluating WHO-Recommended Interventions for Preterm Birth: A Mathematical Model of the Potential Reduction of Preterm Mortality in Sub-Saharan Africa
por: Griffin, Jennifer B., et al.
Publicado: (2019)

Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection
por: Elsheikh, Mosaab E. A., et al.
Publicado: (2022)

Comparison between Adult Patients with Sickle Cell Disease of Sub-Saharan African Origin Born in Metropolitan France and in Sub-Saharan Africa
por: Honsel, Vasco, et al.
Publicado: (2019)

The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis
por: Xu, Ru, et al.
Publicado: (2022)

Data-driven analyses of behavioral strategies to eliminate cysticercosis in sub-Saharan Africa
por: Skrip, Laura A., et al.
Publicado: (2021)

Rethinking the Top-Down Approach to Schistosomiasis Control and Elimination in Sub-Saharan Africa
por: Onasanya, Adeola, et al.
Publicado: (2021)

Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients
por: Pedergnana, Vincent, et al.
Publicado: (2019)

Bis{[(η(5))-cyclopentadienyl]tris(diethyl phosphito-κ(3) P,P′,P′′)cobaltate(III)-κ(3) O,O′,O′′]oxovanadium(IV)}-μ-oxalate
por: McLauchlan, Craig C., et al.
Publicado: (2008)

An interferon lambda 4-associated variant in the hepatitis C virus RNA polymerase affects viral replication in infected cells
por: Bamford, Connor G.G., et al.
Publicado: (2020)

Corrigendum: An interferon lambda 4-associated variant in the hepatitis C virus RNA polymerase affects viral replication in infected cells
por: Bamford, Connor G.G., et al.
Publicado: (2022)

Healthcare Cybersecurity Ethical Concerns during the COVID-19 Global Pandemic: A Rapid Review
por: Lieneck, Cristian, et al.
Publicado: (2023)

Discovery of Novel Alphacoronaviruses in European Rodents and Shrews
por: Tsoleridis, Theocharis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8jirq5l9usllqf0fhdqro7hr34